Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mint Med vs Vitara RX

By GLP-1 ScorecardUpdated

Mint MedFactor scores not reassessed.
Site position #44

Lower score

Vitara RXFactor scores not reassessed.
Site position #10

Higher score

Score comparison

Vitara RX has the higher recorded score — 86/100 to 78.7/100.

Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded GLP-1 marketplace with conflicting advertised prices and unresolved shipping-policy details.

Before you choose

Mint Med does not publish a semaglutide price, so its Mint Med review sets out what it does disclose, while the Vitara RX review explains the conditions attached to Vitara RX's figure. The semaglutide cost page compares published rates across the field. Ask Mint Med for a written total before treating either one as the cheaper choice.

If neither one fits, Bon Health vs Mint Med and Mirabel Meds vs Vitara RX compare each of them with another graded program, and the list of alternatives to Mint Med ranks the programs closest to Mint Med on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Eden review covers one graded close to these two, at 81.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueVitara RX +3
90
93
Dose & formulationEven
80
80
Clinical oversightVitara RX +30
55
85
Labs & monitoringEven
83
83
FulfillmentVitara RX +5
82
87
Contract termsEven
86
86
Mint Med · top barVitara RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMint MedVitara RX
WeighScore78.7/10086/100
GradeC+B
Site position#44#10
SemaglutideProduct and catalog prices conflict; confirm selected plan charge and supply.Advertised from $99/month with an annual plan and discount code ($279 reference); conflicting displays—confirm selected charge.
TirzepatideCatalog title and starting price differ; confirm selected charge and supply.Advertised from $198/month with an annual plan and discount code ($389 reference); conflicting displays—confirm selected charge.
CoverageHomepage says 35 states but lists 36; confirm treatment-specific eligibility.Site lists 49 states, Alaska omitted; confirm medication-specific availability
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Mint Med

Site position #44 · C+

Factor scores not reassessed.

FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.

Strengths

  • Published monthly and prepaid plan choices
  • Portal access for treatment questions

What to consider

  • Advertised prices conflict
  • Processed orders generally final
  • Prepaid cancellation can require repricing
  • Assigned pharmacy and clinician need confirmation
Vitara RX

Site position #10 · B

Factor scores not reassessed.

Strengths

  • Named compounded semaglutide and tirzepatide offerings
  • Ongoing provider messaging advertised
  • Terms allow directing prescriptions to another pharmacy

What to consider

  • Prices changed with a November site rebuild; annual-plan and discount-code conditions need confirming
  • FAQ, terms and returns pages cited earlier no longer load
  • Published list omitted Alaska
  • Refrigeration instructions conflict with the returns policy
  • No universal lab schedule or testing price established
  • Website policy descriptions leave clinical and dispensing roles unclear

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard